Cargando…
Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice
SIMPLE SUMMARY: A bottleneck in oncology is the translation of results from preclinical models to the clinics. The rate of anticancer drugs that are effective in preclinical studies but fail in clinical trials is more than 95%. In order to test new immunotherapies and to identify the most effective...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251926/ https://www.ncbi.nlm.nih.gov/pubmed/37296949 http://dx.doi.org/10.3390/cancers15112989 |